Evaluation status available after sign-in
About the journal
Cancer Cell International is an open-access journal published by BMC in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 2,790 EUR. Declared review time at DOAJ: 15 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- BMC
- ISSN
- 1475-2867
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,790 EUR
- Articles in DOAJ
- 4285
- Declared review time
- 15 weeks
- Declared peer-review model
- other
- Official website
- https://cancerci.biomedcentral.com
Index listings
- DOAJ · 2003-05-08
- PUBMED · 2001-11-23
- Indexing
- DOAJ · PUBMED
- APC
- 2,790 EUR
- Declared review time (DOAJ)
- 15 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
4285
Most recent article
last month
Average review time (journal-declared via DOAJ)
15weeks
Works in OpenAlex
4838
Last recorded publication year
2026
Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
117
i10-index
3165
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-17
- Added to DOAJ
- 2003-05-08
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- LOCKSSPMC
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 95%
- ORCID iDs in current deposits
- 13%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101139795
Classification4
Subjects (DOAJ)
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogensScience: Biology (General): Cytology
LCC codes
RC254-282QH573-671
Subject areas
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Ferroptosis and cancer prognosis
- Ferroptosis and cancer prognosis
Show all subjects (75)
- Circular RNAs in diseases
- Circular RNAs in diseases
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Circular RNAs in diseases
- Ferroptosis and cancer prognosis
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- RNA modifications and cancer
- RNA modifications and cancer
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Hepatocellular Carcinoma Treatment and Prognosis
- Mechanisms of cancer metastasis
- Cancer, Hypoxia, and Metabolism
- RNA modifications and cancer
- Breast Cancer Treatment Studies
- Glioma Diagnosis and Treatment
- Cancer-related Molecular Pathways
- Head and Neck Cancer Studies
- Immune cells in cancer
- Immune cells in cancer
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Cell death mechanisms and regulation
- Gastric Cancer Management and Outcomes
- Epigenetics and DNA Methylation
- Autophagy in Disease and Therapy
- Autophagy in Disease and Therapy
- Immunotherapy and Immune Responses
- Extracellular vesicles in disease
- Extracellular vesicles in disease
- Extracellular vesicles in disease
- Wnt/β-catenin signaling in development and cancer
- Wnt/β-catenin signaling in development and cancer
- Cell death mechanisms and regulation
- Cell death mechanisms and regulation
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Cancer Research and Treatments
- Cancer-related Molecular Pathways
- Cancer Research and Treatments
- Cancer, Lipids, and Metabolism
- Cancer-related Molecular Pathways
- Pancreatic and Hepatic Oncology Research
- Prostate Cancer Treatment and Research
- RNA Research and Splicing
- RNA Research and Splicing
- Cancer, Lipids, and Metabolism
- Cancer, Lipids, and Metabolism
- Lung Cancer Research Studies
- Ubiquitin and proteasome pathways
- Ubiquitin and proteasome pathways
- Cancer Mechanisms and Therapy
- Cancer Mechanisms and Therapy
- Sarcoma Diagnosis and Treatment
- Microtubule and mitosis dynamics
- Microtubule and mitosis dynamics
- Autophagy in Disease and Therapy
- Glioma Diagnosis and Treatment
- Glioma Diagnosis and Treatment
- Hippo pathway signaling and YAP/TAZ
- Hippo pathway signaling and YAP/TAZ
- Kruppel-like factors research
- Kruppel-like factors research
Keywords (DOAJ)
- cancer cell biology
- cell culture
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ